FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

DiscussionThe treatment frequently used in female acne is systemic antibiotics with many courses, as it is a chronic inflammatory disease. In the context of the recent World Health Organisation (WHO) revelation about the serious, worldwide threat to public health of antibiotic resistance, this trial could give the physician another alternative in the treatment of adult female acne instead of using isotretinoin, which is more complex to manage.Trial registrationClinicalTrials.gov:NCT03334682. Registered on 7 November 2017.
Source: Trials - Category: Research Source Type: clinical trials